About us

DB Biotech is focused on the design and production of high quality rabbit clonal antibodies developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DBB scientific team over a period of 20 years.

DB Biotech monospecific clonal antibodies are uniquely characterized by exceptional

  • specificity,
  • affinity
  • and avidity.

Founded in 2006, DB Biotech has earned an international reputation for the development of high quality antibodies used in research and routine clinical diagnostics.

DB Biotech‘s goal is to establish a new gold-standard for the development and application of antibodies on a daily basis, from background-free western blots, to special quantitative diagnostics, and potential applications of humanized antibodies for disease treatment purposes..